From Ivy Tree Advisors Pharma's commercial and customer experience landscape is undergoing its most significant transformation in a generation. "Better CX" in pharma means less friction, more trustworthy information, and faster time to therapy not better marketing. The imperative has shifted from "should we use AI?" to "are we using it to solve the right problems, in the right workflows, for the right people?"   EXECUTIVE SUMMARY 1. AI driven Next Best Action is delivering me

We're probably at the peak of the AI hype cycle. Your teams have moved beyond experimenting with ChatGPT—they're now integrating AI into...

💊 Bristol-Myers Squibb and Pfizer  are rolling out DTC sales for Eliquis—one of the world’s best-selling blood thinners—at a discount....

Is pharma finally getting AI governance right? After years of cautious experimentation, pharmaceutical companies are finding their rhythm...

The AI-powered drug discovery  platform market is set to reach $1.29 billion in 2025, and surge to $8.27 billion by 2035—a rapid ~20%...

What if the success of AI in pharma R&D depends less on how powerful the models are—and more on whether companies build the right...